Table 1 Echinocandins: some comparative data

From: Increased dose of echinocandins for invasive fungal infections: bonanza for the patient or the pharmaceutical industry?

 

Caspofungin

Micafungin

Anidulafungin

(A) Indications

esophageal candidiasis (EC),

systemic candidiasis,

febrile neutropenia (empiric therapy),

invasive aspergillosis (salvage therapy)

esophageal candidiasis (EC),

prophylaxis of candidiasis

(pre-engraftment

in stem cell transplant)

esophageal candidiasis (EC),

systemic candidiasis (SC)

(B) Dose

   

 Initial

70 mg

No loading dose

100 mg/day (EC)

200 mg/day (SC)

 Maintenance

50 mg/day

150 mg/day (EC)

50 mg/day (for prophylaxis)

50 mg/day (EC)

100 mg/day (SC)

(C) Higher doses found safe (package insert)

100 mg/day × 21 days (15 subjects)

70 mg/day (limited data)

8 mg/kg/day (up to 900 mg/day)

260 mg

followed by 130 mg/day